Tax Consequences Clause Example from Business Contracts
This example Tax Consequences clause appears in 134 contracts from 89 companies
Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for the 2019 Equity... (Filed With SEC on January 18, 2019)
Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan (Filed With SEC on March 18, 2019)
ACLARIS THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on September 25, 2015)
Aclaris Therapeutics, Inc. 2017 Inducement Plan Stock Option Grant Notice (Filed With SEC on August 1, 2017)
Cirius Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on January 11, 2019)
2019 Equity Incentive Plan and forms of grant notice, stock option and restricted stock unit award agreements and notice of exercise thereunder (Filed With SEC on January 29, 2019)
Harpoon Therapeutics, Inc. 2022 Inducement Plan, Form of Stock Option Grant Notice, Option Agreement, Form of Restricted Stock Grant Notice and Restricted Stock Unit Award... (Filed With SEC on June 28, 2022)
Harpoon Therapeutics, Inc. 2019 Equity Incentive Plan and related form agreements (Filed With SEC on August 10, 2022)
Standard Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)
Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice for Inducement Award Recipients under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive... (Filed With SEC on May 9, 2019)
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan (Filed With SEC on June 26, 2019)
Personalis, Inc. 2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 7, 2019)
Turning Point Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise (Filed With SEC on April 8, 2019)
Form of Stock Option Grant Notice and Stock Option Agreement used in connection with the Senseonics Holdings, Inc. Inducement Plan (Filed With SEC on June 5, 2019)
Forms of Option Grant Notice and Option Agreement under 2019 Equity Incentive Plan (Filed With SEC on April 29, 2019)
2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 10, 2019)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise for Inducement Grant Outside of 2013 Equity Incentive Plan (Filed With SEC on August 8, 2019)
Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 27, 2013)
Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 8, 2013)
Form of Option Grant Package under 2019 Equity Incentive Plan (Filed With SEC on August 12, 2019)
Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
Forms of Option Grant Notice and Option Agreement under Vir Biotechnology, Inc. 2019 Equity Incentive Plan (Filed With SEC on September 3, 2019)
Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, to be in effect when this registration... (Filed With SEC on July 8, 2019)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise for 2015 Equity Incentive Plan, as amended (Filed With SEC on August 16, 2019)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 14, 2019)
Form of Stock Option Grant Notice and Stock Option Agreement under Mirati Therapeutics, Inc. Inducement Plan (Filed With SEC on December 31, 2019)
Form of Stock Option Grant Notice and Stock Option Agreement under the GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 28, 2013)
GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 4, 2013)
Form of Stock Option Agreement under the 2019 Inducement Award Plan (Filed With SEC on March 2, 2020)
Form of Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
Form of Director Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
Form of Director Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
INTRA-CELLULAR THERAPIES, INC. 2013 EQUITY INCENTIVE PLAN OPTION GRANT NOTICE (Filed With SEC on March 25, 2014)
Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 27, 2019)
Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 8, 2018)
Form of Stock Option Grant Notice and Option Agreement for the 2020 Equity Incentive Plan (Filed With SEC on September 28, 2020)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Director) (Filed With SEC on December 23, 2020)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Nuwellis, Inc. 2021 Inducement Plan (Filed With SEC on May 20, 2021)
SUNSHINE HEART, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on May 30, 2017)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (Filed With SEC on October 4, 2021)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan (Filed With SEC on November 4, 2021)
2022 Equity Incentive PlanForm of Option Grant Notice & Stock Option Agreement to become effective immediately prior to the Effective Date of this Offering (Filed With SEC on January 6, 2022)
ContraFect Corporation 2021 Employment Inducement Omnibus Incentive Plan and related forms of notice and option agreement (Filed With SEC on May 16, 2022)
Form of Option Grant Notice and Award Agreement under the Everbridge, Inc. 2022 Inducement Incentive Plan (Filed With SEC on December 20, 2022)
EVERBRIDGE, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ], 2016 APPROVED BY THESTOCKHOLDERS: [ ], 2016 EFFECTIVEDATE: [ ], 2016 (Filed With SEC on September 6, 2016)
2018 Equity Incentive Plan and Forms of Stock Option Grant Notice and Agreement and Restricted Stock Unit Grant Notice and Agreement thereunder (Filed With SEC on October 5, 2018)
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the 2018 Equity Incentive Plan (Filed With SEC on October 5, 2018)
Synthorx, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock... (Filed With SEC on November 27, 2018)
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit... (Filed With SEC on October 2, 2018)
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on October 2, 2018)
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 17, 2018)
Forms of grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on July 17, 2018)
Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2021 Inducement Plan (Filed With SEC on March 30, 2023)
Forms of grant notice, stock option agreement and notice of exercise under the 2018 Equity Incentive Plan (to be effective upon the closing of this offering) (Filed With SEC on May 31, 2018)
Forms of Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan (Filed With SEC on May 24, 2018)
2018 Equity Incentive Plan and Forms of Stock Option Grant Notice and Agreement and Restricted Stock Unit Grant Notice and Agreement thereunder (Filed With SEC on June 29, 2018)
Form of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice, and Restricted Stock Unit Award Agreement under 2018 Equity Incentive Plan (Filed With SEC on June 5, 2018)
Forms of agreements and award grant notices under the 2018 Equity Incentive Plan (Filed With SEC on May 2, 2018)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 30, 2018)
Form of Stock Option Grant Notice and Option Agreement for employees under the 2014 Equity Incentive Plan (Filed With SEC on March 30, 2018)
Form of Stock Option Grant Notice and Option Agreement for non-employee directors under the 2014 Equity Incentive Plan (Filed With SEC on March 30, 2018)
ThresholdPharmaceuticals, Inc. Stock OptionGrant Notice (2014 Equity IncentivePlan) (Filed With SEC on May 21, 2014)
ThresholdPharmaceuticals, Inc. StockOption Grant Notice (2014Equity Incentive Plan) OptionGrant Non-EmployeeDirector Compensation Policy (Filed With SEC on May 21, 2014)
Xencor, Inc. 2013 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder (Filed With SEC on February 28, 2018)
Form of Stock Option Grant Notice and Option Agreement under the 2017 Equity Incentive Plan (Filed With SEC on March 19, 2018)
Form of Option Grant Package under 2015 Equity Incentive Plan (Filed With SEC on February 28, 2018)
ALARM.COM HOLDINGS, INC. STOCK OPTION GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on February 29, 2016)
ALARM.COM HOLDINGS, INC. STOCK OPTION GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on June 11, 2015)
2018 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice thereunder (Filed With SEC on January 29, 2018)
SNAP INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on February 2, 2017)
RIGEL PHARMACEUTICALS, INC. INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 11, 2016)
PROTAGONIST THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 28, 2016 APPROVED BY THE STOCKHOLDERS:JULY 31, 2016 EFFECTIVE DATE: JULY 28, 2016 (Filed With SEC on August 1, 2016)
Instructure, Inc. 2015 Equity Incentive Plan Stock Option Grant Notice (Filed With SEC on May 6, 2016)
INSTRUCTURE, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 9, 2015)
TREVENA, INC. FORM OF STOCK OPTION GRANT NOTICE (INDUCEMENT PLAN) (Filed With SEC on December 19, 2016)
TREVENA, INC. FORM OF STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on May 7, 2015)
EVERSPIN TECHNOLOGIES, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 25, 2016 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 20, 2016 IPO DATE: , 2016 (Filed With SEC on September 26, 2016)
EVERSPIN TECHNOLOGIES, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:APRIL 25, 2016 APPROVED BY THE STOCKHOLDERS:[ ] IPO DATE: [ ] (Filed With SEC on September 9, 2016)
BoneBiologics Corporation Stock Option Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on January 4, 2016)
MOBILEIRON, INC. 2015 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on January 6, 2016)
MOBILE IRON, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on April 23, 2014)
MOBILEIRON, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on May 29, 2014)
MOBILEIRON, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 31, 2014)
SIGNAL GENETICS, INC. 2016 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on December 2, 2016)
Sientra, Inc. Inducement Plan Adopted by the Board of Directors: March 7, 2016 (Filed With SEC on March 10, 2016)
SIENTRA, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD: October 10, 2014 APPROVED BY THE STOCKHOLDERS: October 10, 2014 IPO DATE/EFFECTIVE DATE: [], 2014 (Filed With SEC on October 20, 2014)
Oncobiologics,Inc. 2015 Equity Incentive Plan StockOption Grant Notice (Filed With SEC on January 15, 2016)
PARATEK PHARMACEUTICALS, INC. 2015 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on February 10, 2015)
Paratek Pharmaceuticals, Inc. Stock Option Grant Notice (2017 Inducement Plan) (Filed With SEC on June 16, 2017)
SCYNEXIS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 11,2014 APPROVED BY THE STOCKHOLDERS: February 25, 2014 EFFECTIVE DATE: February 11, 2014 (Filed With SEC on March 19, 2014)
SCYNEXIS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 11,2014 APPROVED BY THE STOCKHOLDERS: February 25, 2014 EFFECTIVE DATE: February 11, 2014 (Filed With SEC on February 27, 2014)
SCYNEXIS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 11,2014 APPROVED BY THE STOCKHOLDERS: February 25, 2014 EFFECTIVE DATE: February 11, 2014 (Filed With SEC on April 30, 2014)
EASIC CORPORATION 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 18, 2015 APPROVED BY THE STOCKHOLDERS:[ ], 2015 IPO DATE:[ ], 2015 (Filed With SEC on February 19, 2015)
INFRAREDX, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 15, 2015 APPROVED BY THE STOCKHOLDERS:JANUARY 16, 2015 IPO DATE/EFFECTIVE DATE: , 2015 (Filed With SEC on January 20, 2015)
INTERSECT ENT, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY, 2014 APPROVED BY THE STOCKHOLDERS:[ ], 2014 IPO DATE/EFFECTIVEDATE: [ ], 2014 (Filed With SEC on July 9, 2014)
INTERSECT ENT, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 7, 2014 APPROVED BY THE STOCKHOLDERS:JULY 10, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on July 14, 2014)
GLOBEIMMUNE, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on March 17, 2014)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 AMENDED BY THE BOARD OFDIRECTORS: SEPTEMBER 11, 2013 APPROVED BY... (Filed With SEC on January 22, 2014)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 AMENDED BY THE BOARD OFDIRECTORS: SEPTEMBER 11, 2013 APPROVED BY... (Filed With SEC on November 1, 2013)
CELLADON CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 APPROVED BY THE STOCKHOLDERS:OCTOBER 10, 2013 IPO DATE: ,2013 (Filed With SEC on October 11, 2013)
ALTHEADX, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 19, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 22, 2015 IPO DATE: [],2015 (Filed With SEC on January 23, 2015)
ALTHEADX, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2014 APPROVED BY THESTOCKHOLDERS: [], 2014 IPO DATE:[], 2014 (Filed With SEC on December 23, 2014)
FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: JANUARY 27, 2014 (Filed With SEC on January 29, 2014)
FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE: , 2013 (Filed With SEC on January 8, 2014)
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on August 29, 2014)
CALITHERA BIOSCIENCES, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on September 25, 2014)
HEALTHEQUITY, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 30, 2014 AMENDED AND RESTATED BYTHE BOARD OF DIRECTORS: JULY 14, 2014 APPROVED BY THE... (Filed With SEC on July 16, 2014)
NEW RELIC, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:NOVEMBER 25, 2014 APPROVED BY THE STOCKHOLDERS:[], 2014 IPO DATE: [], 2014 (Filed With SEC on December 1, 2014)
ARIOSA DIAGNOSTICS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on April 16, 2014)
TRIVASCULAR TECHNOLOGIES, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY BOARD: [ ],2014 APPROVED BY STOCKHOLDERS:[ ], 2014 EFFECTIVEDATE/INITIAL PUBLIC OFFERING DATE: [ ], 2014 (Filed With SEC on April 3, 2014)
ADURO BIOTECH, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on April 6, 2015)
EAGLE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 201 APPROVED BY THE STOCKHOLDERS: , 201 IPO DATE: , 201 (Filed With SEC on January 22, 2014)
EAGLE PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on December 21, 2015)
CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2015 APPROVED BY THESTOCKHOLDERS: [], 2015 IPO DATE:[], 2015 (Filed With SEC on March 13, 2015)
CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 27, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE: [],2015 (Filed With SEC on April 6, 2015)
FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on October 24, 2014)
FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on November 12, 2014)
ATARA BIOTHERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on June 20, 2014)
RAPID7,INC. 2015EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY , 2015 APPROVED BY THESTOCKHOLDERS: JULY , 2015 EFFECTIVEDATE: JULY , 2015 (Filed With SEC on July 6, 2015)
SYNCARDIA SYSTEMS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JUNE 18, 2015 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 14, 2015 (Filed With SEC on September 16, 2015)
Forms of grant notice, stock option agreement and notice of exercise under the Stitch Fix, Inc. 2017 Incentive Plan (Filed With SEC on November 6, 2017)
Form of Option Agreement - Inducement Plan (Filed With SEC on November 9, 2017)
PORTOLA PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 30, 2013 AMENDED BY THE BOARDOF DIRECTORS: FEBRUARY 27, 2013 APPROVED BYTHE... (Filed With SEC on April 12, 2013)
Form of Stock Option Grant Notice and Stock Option Agreement under 2017 Equity Incentive Plan (Filed With SEC on October 30, 2017)
APPIAN CORPORATION 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 2017 APPROVED BY THE STOCKHOLDERS: , 2017 IPODATE: , 2017 (Filed With SEC on May 10, 2017)
RALLY SOFTWARE DEVELOPMENT CORP. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on March 22, 2013)
AMBIT BIOSCIENCES CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 12, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE/EFFECTIVE DATE: , 2013 (Filed With SEC on February 20, 2013)
AMBIT BIOSCIENCES CORPORATION 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 12, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE/EFFECTIVE DATE: , 2013 (Filed With SEC on April 25, 2013)
TABLEAU SOFTWARE, INC. 2013EQUITY INCENTIVE PLAN OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORYSTOCK OPTION) (Filed With SEC on April 2, 2013)
MEDICINOVA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on November 7, 2013)
